Business France will bring together 88 French healthcare firms on three pavilions, who will present their smart solutions designed to tackle the current health challenges, at Arab Health from January 30 to February 2 in Dubai. 

 

Gathered under the banner of the French Healthcare in partnership with the French Healthcare association, renowned French companies including Rebalance Tech, Eurasanté and Devup will participate in the event. 

 

The event will also be marked by the visit of Jean Patrick Lajonchère, Export Health Federator to the Minister for Europe and Foreign Affaires’ and to the Minister Foreign Trade and Attractiveness on January 30 and 31. 

 

Strong presence

In a country committed in terms of improving the healthcare system, France has a strong presence with renowned and qualified actors such as Ipsen, Servier, Sanofi, Pierre Fabre to name just a few. Arab Health will be the opportunity for more French players to come and explore the market and develop strong ties with the local partners.   

 

In September 2022, four major not-for-profit French hospitals: Curie Institute, Paris Saint-Joseph and Marie- Lannelongue Hospitals, Rothschild Foundation Hospital and the medical services and consulting company C3Medical have announced their collaboration in opening an office in Dubai in order to better address the needs of the population in Middle East. 

 

In mid-June 2022, French pharmaceutical giant Sanofi signed an agreement with the Abu Dhabi Ministry of Health aiming to work on four distinct healthcare priorities, involving extensive R&D as well.

 

Sanofi deal

As part of this, Sanofi will extend its hand for a clinical research project and patient recruitment protocol as well as participate in DoH’s Cancer Advisory Group to ‘develop policies significant to the elderly cancer-patient community’. Both will also ‘co-create’ a high-risk population screening project that will support in the detection of rare metabolic diseases utilising AI tools.

 

France enjoys a worldwide renowned image for the quality of its healthcare offer as well as for its industrial, technical and scientific expertise. It stands out all over the world thanks to its health performance. A leader in the fight against cancer, it has one of the best cure rates and has more than 130 research projects and 13 Nobel Prizes in medicine.

 

Axel Baroux, French Trade & Invest Commissioner & Managing Director of Business France Middle East, commented: “I believe that French Healthcare companies will explore new partnerships with the local healthcare professionals.”

 

“Facilitating access to care, improving the health system and providing new technologies and services for the patients are a common ambition between the French-UAE healthcare authorities and systems,” added Baroux.

 

French companies are redoubling their ingenuity by proposing innovative concepts. R&D efforts are considerable: 6% of sales in 2020, making innovation the central element in the development strategies of French companies. France's expertise is based on national research centers, competitive clusters and universities that place it at the forefront of global health research. France is ranked number 5th in the world for the number of patents filed.

 

Rebalance Impulse

The French Company Rebalance Tech has developed a revolutionary mental wellness & neuro-relaxation solution: Rebalance Impulse. This stimulation and cognitive training device based on applied neuroscience is mainly devoted to fighting chronic stress, improving sleep quality, and increasing vitality. The effectiveness of Rebalance Impulse has been the subject of clinical studies, published in the world-renowned scientific journal: Frontiers in Psychology.

 

Rebalance Impulse operates in the following markets: medwellness, professional sports, healthcare, and corporate. The programs integrated in this innovative and non-invasive solution target: Neuro-Relaxation, Sleep, Addictions, Memory & Concentration, Pain Management, Emotions Management, Slimming, Brain Anti-Aging, Long Covid Recovery, and Post-Traumatic Stress Disorder (EMDR). 

 

French industrial production includes 1,440 MedTech companies, 93% of which are small and medium-sized companies that together employ 88,000 people. Some companies generate more than 50% of their turnover abroad, such as Médipréma, which has developed a phototherapy solution adapted for neonatology.

 

The MedTech sector is very dynamic thanks to its innovative companies. It includes all medical devices - surgical robots, telemedicine objects, medical imaging, but also artificial hearts as well as respirators.  

 

The potential of French medical technologies is growing rapidly thanks to artificial intelligence, connected objects and quantum technology. These are all applications that should continue to develop strongly, while adapting to the different needs of patients, but also of health professionals. With the company ATA Medical, which has adapted to the recent health issues: thanks to the DOPAIR1000, a specialised and connected solution for air treatment in hygiene environments.-- TradeArabia News Service